Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Healthy Male Volunteers

Clinical trial NCT01134549 · COMPLETED

Trial details

NCT number: NCT01134549
Sponsor: KAI Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hyperparathyroidism, Secondary

Start date: 2010-06-09
Primary completion: 2010-07-31
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.